Introduction: Plant products are a rich source of pharmacologically active molecules and are considered an
important and attractive field of scientific investigation for the development of new drugs. The present study
aimed to assess the α-amylase, α-glucosidase and lipase enzymes inhibitory activities and the cytotoxic effects of
Carlina curetum four solvents fractions in order to better understand the anti-obesity, hypoglycemic and anticancer
effects of this plant.
Methods: Several qualitative and quantitative phytochemical tests were performed on Carlina curetum solvent
fractions utilizing standard phytochemical procedures, followed by an investigation into their ability to inhibit
the enzymes α-amylase, α-glucosidase, and lipase and an assessment of cytotoxic activity against HeLa and Colo-
205 cells using standard biochemical and biotechnological methods.
Results: The results revealed that the aqueous and methanol fractions had the highest α-amylase enzyme inhibitory
activity with IC50 values of 21.37±0.31 and 30.2±0.42 μg/mL, respectively, in comparison with
Acarbose, which had an IC50 value of 28.18±0.42 μg/mL. The methanol fraction showed potent α-glucosidase
inhibitory activity with an IC50 value of 27.54±4.28 μg/mL; the α-glucosidase inhibitory activity Acarbose was
37.15±0.33 μg/mL. The hexane fraction had greater anti-lipase activity than Orlistat. In addition, 0.5 mg/mL
of the C. curetum acetone and hexane fractions had pronounced cytotoxic effects on the Colo-205 cancer cell line,
and 0.625 mg/ml of the C. curetum hexane fraction had potential cytotoxic effects against the cervical epithelial
carcinoma (HeLa) cell line.
Conclusion: This study revealed that C. curetum has potential α-amylase, α-glucosidase, porcine pancreatic lipase
enzyme inhibitory activity and cytotoxic activity against the HeLa and Colo-205 cancer cell lines, which indicates
the presence of biologically active and cytotoxic compounds in this plant species. This may be considered
a challenge for developing bioactive compounds in diabetes, obesity and cancer management.

العنوان

European Journal of Integrative Medicine

الناشر

Elsevier

بلد الناشر

الولايات المتحدة الأمريكية

Indexing

Thomson Reuters

معامل التأثير

0,95

نوع المنشور

Both (Printed and Online)

المجلد

30

السنة

2019

الصفحات

100933